- Home
- AXDX vs CLDI Comparison
AXDX vs CLDI Comparison
Compare AXDX & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXDX
- CLDI
- Stock Information
- Founded
- AXDX 1982
- CLDI 2014
- Country
- AXDX United States
- CLDI United States
- Employees
- AXDX N/A
- CLDI N/A
- Industry
- AXDX Biotechnology: Laboratory Analytical Instruments
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AXDX Industrials
- CLDI Health Care
- Exchange
- AXDX Nasdaq
- CLDI Nasdaq
- Market Cap
- AXDX 27.0M
- CLDI 22.3M
- IPO Year
- AXDX 1996
- CLDI N/A
- Fundamental
- Price
- AXDX $0.71
- CLDI $0.56
- Analyst Decision
- AXDX Hold
- CLDI Strong Buy
- Analyst Count
- AXDX 1
- CLDI 2
- Target Price
- AXDX $1.00
- CLDI $15.00
- AVG Volume (30 Days)
- AXDX 49.1K
- CLDI 433.2K
- Earning Date
- AXDX 03-21-2025
- CLDI 05-13-2025
- Dividend Yield
- AXDX N/A
- CLDI N/A
- EPS Growth
- AXDX N/A
- CLDI N/A
- EPS
- AXDX N/A
- CLDI N/A
- Revenue
- AXDX $11,698,000.00
- CLDI N/A
- Revenue This Year
- AXDX $7.25
- CLDI N/A
- Revenue Next Year
- AXDX N/A
- CLDI N/A
- P/E Ratio
- AXDX N/A
- CLDI N/A
- Revenue Growth
- AXDX N/A
- CLDI N/A
- 52 Week Low
- AXDX $0.69
- CLDI $0.54
- 52 Week High
- AXDX $2.09
- CLDI $8.30
- Technical
- Relative Strength Index (RSI)
- AXDX 22.43
- CLDI 30.41
- Support Level
- AXDX $0.69
- CLDI $0.66
- Resistance Level
- AXDX $1.09
- CLDI $0.79
- Average True Range (ATR)
- AXDX 0.11
- CLDI 0.06
- MACD
- AXDX -0.04
- CLDI -0.01
- Stochastic Oscillator
- AXDX 2.93
- CLDI 7.72
About AXDX Accelerate Diagnostics Inc.
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.